AHMEDABAD, 21 FEBRUARY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

JP Morgan on JSW Energy: Initiate Overweight on Company, target price at Rs 545 (Positive)

MS on KEI Ind: Initiate Overweight on Company, target price at Rs 4391 (Positive)

BofA on Hindalco: Maintain Buy on Company, target price at Rs 725 (Positive)

UBS on APL Apollo: Maintain Buy on Company, target price at Rs 2000 (Positive)

Nomura on Axis Bank: Maintain Buy on Bank, target price at Rs 1230 (Positive)

MS on Indian Hotels: Maintain Overweight on Company, target price at Rs 856 (Positive)

Elara on Adani Energy: Initiate Buy on Company, target price at Rs 930 (Positive)

Investec on Suzlon: Initiate Buy on Company, target price at Rs 70 (Positive)

MOSL on Adani Ports: Maintain Buy on Company, target price at Rs 1400 (Positive)

MOSL on JSW Infra: Maintain Buy on Company, target price at Rs 330 (Positive)

MOSL on HDFC Bank: Maintain Buy on Bank, target price at Rs 2050 (Positive)

Jefferies on Healthcare sector: Hospital stocks offer superior earnings visibility in an otherwise uncertain market environment. Prefers Max Health, Fortis and Apollo Hospitals (Positive)

Nomura on NBFCs: Credit costs appear to have peaked, setting stage for improved profitability in coming qtrs. Top Picks Shriram Fin, Aadhar and BajFin (Positive)

Citi on Pharma: Believe tariffs on Indian generics and APIs exports to the US are unlikely at this point. Due to the uncertainty, stocks may remain volatile (Neutral)

JP Morgan on Indian Consumer: Pace of price hikes has risen, necessitated by persisting inflation in various agri commodities (edible oil, tea, coffee, cocoa). DMART continuing to maintain its price leadership (Neutral)

Citi on OMCs: OMCs could end FY25E on an ugly note. Implied FY25E dividend yields could be meaningfully lower for BPCL/HPCL/IOCL (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)